Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Zentalis Pharmaceuticals Inc (ZNTL)

Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Zentalis Pharmaceuticals Appoints Wendy Chang as Chief People Officer and Haibo Wang as Chief Business Officer Quiver Quantitative, Inc. - Thu Dec 12, 4:20PM CST

Zentalis Pharmaceuticals announced the appointments of Wendy Chang and Haibo Wang to leadership positions to advance azenosertib's development.Quiver AI SummaryZentalis Pharmaceuticals announced the appointment...

ZNTL : 3.00 (+2.39%)
Zentalis Pharmaceuticals Announces Key Management Appointments GlobeNewswire - Thu Dec 12, 6:00AM CST

ZNTL : 3.00 (+2.39%)
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon Dec 2, 3:35PM CST

ZNTL : 3.00 (+2.39%)
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib GlobeNewswire - Wed Nov 13, 7:00AM CST

ZNTL : 3.00 (+2.39%)
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Nov 1, 6:04PM CDT

ZNTL : 3.00 (+2.39%)
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% BayStreet.ca - Fri Oct 4, 8:19AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Although death rates for some cancers are declining, the world is facing a sharp increase in cancer...

ONCY : 0.8310 (-6.36%)
ZNTL : 3.00 (+2.39%)
TIL : 20.61 (+2.64%)
IMRX : 2.00 (+8.70%)
ZLAB : 26.72 (+1.91%)
ONC.TO : 1.19 (-9.16%)
Why Shares of Zentalis Pharmaceuticals Dropped This Week Motley Fool - Fri Jun 2, 2023

A rash of insider selling meant the stock gave back some of its gains from last week.

RHHBY : 34.5000 (+0.76%)
ZNTL : 3.00 (+2.39%)
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL) Business Wire - Tue Jan 10, 2023

Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) (“Zentalis” or the “Company”). The investigations...

ZNTL : 3.00 (+2.39%)
Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm PR Newswire - Thu Dec 29, 2022

/PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Zentalis...

ZNTL : 3.00 (+2.39%)
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update Globe Newswire - Tue Aug 9, 2022

Strengthened leadership team with the appointment of additional industry veterans, including CEO Dr. Kimberly Blackwell and Chairman Dave Johnson Received...

ZNTL : 3.00 (+2.39%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - Sun Dec 22, 9:30AM CST
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot